Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
about
A Developmental Psychopathology Perspective on ADHD and Comorbid Conditions: The Role of Emotion RegulationEvidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorderCognitive-behavioral therapy for anxiety disorders in youthCognitive behavioral therapy age effects in child and adolescent anxiety: an individual patient data metaanalysisPaediatric Obsessive-Compulsive Disorder and Depressive Symptoms: Clinical Correlates and CBT Treatment OutcomesThe effects of temporally secondary co-morbid mental disorders on the associations of DSM-IV ADHD with adverse outcomes in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A).Comorbidity in youth with specific phobias: Impact of comorbidity on treatment outcome and the impact of treatment on comorbid disorders.Serotonin transporter [corrected] methylation and response to cognitive behaviour therapy in children with anxiety disorders.Evidence Base Update: 50 Years of Research on Treatment for Child and Adolescent Anxiety.Co-occurrence of ODD and Anxiety: Shared Risk Processes and Evidence for a Dual-Pathway Model.Specific phobias in youth: a randomized controlled trial comparing one-session treatment to a parent-augmented one-session treatmentWhy are anxiety and depressive symptoms comorbid in youth? A multi-wave, longitudinal examination of competing etiological models.Predictors of treatment attrition among an outpatient clinic sample of youths with clinically significant anxietyChildren With Conduct Problems and Co-occurring ADHD: Behavioral Improvements Following Parent Management Training.Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorderUsability evaluation with mental health professionals and young people to develop an Internet-based cognitive-behaviour therapy program for adolescents with anxiety disordersNeurotrophic gene polymorphisms and response to psychological therapy.Review: Comprehensive treatments for youth comorbidity - evidence-guided approaches to a complicated problemSeverity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication Adolescent SupplementEpigenetic Modulation of Mood Disorders.Predictors of rate of change for children and youth with emotional disorders: a naturalistic observational study.DTI-measured white matter abnormalities in adolescents with Conduct Disorder.A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth.Cognitive behavior therapy for anxious adolescents: developmental influences on treatment design and delivery.Prognostic factors of improvement in health-related quality of life in atomoxetine-treated children and adolescents with attention-deficit/hyperactivity disorder, based on a pooled analysis.Attention and Executive Function in Children Diagnosed with Attention Deficit Hyperactivity Disorder and Comorbid Disorders.Predictors of Treatment Effectiveness for Youth with ASD and Comorbid Anxiety Disorders: It all Depends on the Family?Comorbidity of anxiety and depression in children and adolescents: 20 years after.How oppositionality, inattention, and hyperactivity affect response to atomoxetine versus methylphenidate: a pooled meta-analysis.Integrating etiological models of social anxiety and depression in youth: evidence for a cumulative interpersonal risk model.Predictors and moderators of outcome in child and adolescent anxiety and depression: a systematic review of psychological treatment studies.Co-occurring mental health problems and peer functioning among youth with attention-deficit/hyperactivity disorder: a review and recommendations for future research.Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).The role of day-to-day emotions, sleep, and social interactions in pediatric anxiety treatment.Engagement in Behavioral Parent Training: Review of the Literature and Implications for Practice.Long-Term Effects of the Family Check-Up in Public Secondary School on Diagnosed Major Depressive Disorder in Adulthood.Predictors of Response to Behavioral Treatments Among Children With ADHD-Inattentive Type.Practitioner Review: Empirical evolution of youth psychotherapy toward transdiagnostic approaches.Evidence-based youth psychotherapy in the mental health ecosystem.A Randomized Clinical Trial Comparing Individual Cognitive Behavioral Therapy and Child-Centered Therapy for Child Anxiety Disorders.
P2860
Q22061957-A563FCE3-42FE-447C-928B-42C5DD9D3CCBQ22242980-334C522A-9933-477F-9A03-35F476175413Q22252303-0DFD0C24-4589-44F2-8373-AF811ADC67F3Q30622959-FCE879AB-2657-4CFF-996B-CA190AD38081Q30654275-820770B3-0FF6-4EB8-A70C-F4CA2828F654Q34014855-ACE569F1-F50C-4F5F-932A-737498EF970DQ34036838-54FAC5BD-D2AB-4C33-BA8F-8D84DC8A479CQ34370497-6E2F7F0B-A702-4C42-8A07-74DD2CF895DDQ34481292-073C8288-4109-4F27-9594-44E4AE2D79D9Q34717850-A1DB58BA-D669-430E-9496-C4AA19B3258EQ35057130-5DE43CAF-8C6E-4FD2-8D33-2A3D9D0330D1Q35111912-95216ECC-4530-4C6F-B350-351BB1D60134Q35132198-8D946732-79CB-4321-A869-99B3D96B9537Q35407743-69AC64EC-7251-4104-910F-091A4177CD3BQ35486056-7F7F6AFE-F45A-4DF8-A884-51216A182C19Q35870881-8167C07F-A172-42DE-93AE-8CA197200C70Q36001550-2A2A4E6A-7A60-4768-87B6-FC565079C0B4Q36071771-C90FD711-BB1F-47F4-8240-C2916C13BB60Q36466160-8C1F8F6D-7588-433D-BDDF-4784EE1E41B7Q36737217-A284C23C-957A-4A00-8281-0A2BB113ECE4Q36871300-EF6C1C02-2FC8-4568-BEE5-6885A3AA3A82Q37393131-641856D6-5050-4484-8FA2-1F0813C13064Q37486324-89755C25-0755-4B7D-9557-6C82D33E90A1Q37537159-51DF7863-6145-46DB-9B36-F0B72D9D1645Q37603815-65D526C7-1F6A-46C0-8167-AF53CED91A82Q37698434-79770DEA-17BA-487F-8FA2-2126D5B473F5Q37703248-5CDC3315-2255-494B-8F28-D039800B4626Q37735507-113CA3BA-8FC4-4C4F-918D-B8A79B8AF368Q37834860-A198E58D-C7B7-4018-B263-91ED18982D56Q37955671-1F427629-3C8A-43A7-8BC4-66FCFF0B2B82Q38038080-71FCBD26-15AA-46B4-B81C-E7A772629FBEQ38042400-68A61831-328F-4DBE-919F-54741A026EF9Q38251282-8BCBE9BF-1E6D-427D-A1B5-1D4EF181D93BQ38778381-FCB3324D-BD86-4069-82D8-123ECCCAEBAFQ38867356-0FB9A592-6002-4596-95C3-4F161BFC141EQ38878314-49511F4D-F317-4EB3-B898-A04FE301943EQ39223712-CBD0B96D-2440-4AAD-96EB-C3028740297EQ39332443-C9BEE26C-9D0C-4862-A532-8B92A0F59935Q39468534-55B22209-CADD-4D25-89BE-67FB7F2D9374Q40924373-E3844418-DB5E-4DC5-8825-1FEE8CE88C48
P2860
Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@en
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@nl
type
label
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@en
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@nl
prefLabel
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@en
Comorbidity as a predictor and ...... ppositional/conduct disorders.
@nl
P2093
P1476
Comorbidity as a predictor and ...... oppositional/conduct disorders
@en
P2093
Amie E Grills-Taquechel
Laura D Hovey
Matthew A Jarrett
Thomas H Ollendick
P304
P356
10.1016/J.CPR.2008.09.003
P577
2008-09-17T00:00:00Z